Clinical trial
Nevirapine Resistance Study: Nevirapine Resistance Among HIV-Infected Mothers
NCT00164762 · Centers for Disease Control and Prevention, U.S. Fed · Completed
Key facts
| NCT number | NCT00164762 |
|---|---|
| Title | Nevirapine Resistance Study: Nevirapine Resistance Among HIV-Infected Mothers |
| Official title | Nevirapine Pharmacodynamics and Resistance Among HIV-Infected Mothers in Lilongwe, Malawi |
| Lead sponsor | Centers for Disease Control and Prevention, U.S. Fed |
| Collaborators | Kamuzu Central Hospital University of North Carolina |
| Status | Completed |
| Study type | Observational |
| Conditions | HIV Infections |
| Enrollment | 126 |
| Start date | Jun 1, 2005 |
| Completion | Nov 1, 2006 |
| First posted | Sep 14, 2005 |
| Last update posted | Oct 1, 2007 |
| Countries | Malawi |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: